Status:
TERMINATED
Genetic Predictors of Outcome in HCM Patients
Lead Sponsor:
University of Pittsburgh
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective review of the data available on patients and their family members with HCM and prospective follow-up of this cohort for clinical outcome and diagnostic studies. Genetic samples...
Detailed Description
This is a retrospective review of the data available on patients and their family members with HCM and prospective follow-up of this cohort for clinical outcome and diagnostic studies. Genetic samples...
Eligibility Criteria
Inclusion
- 18+ years of age
- Diagnosed with HCM defined by the presence of left ventricular hypertrophy with minimal wall thickness \>/= 15mm without the presence of hypertension or systemic disease that can account for the degree of hypertrophy.
Exclusion
- Hypertension present prior to the diagnosis of HCM
- aortic stenosis with aortic valve area \< 1cm2
- known systemic disease that can cause LVH, such as infiltrative diseases
- able and willing to provide informed consent
Key Trial Info
Start Date :
April 22 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00156429
Start Date
April 22 2009
End Date
July 30 2020
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States, 15213